'A Poor Measure' | GenomeWeb

'A Poor Measure'

H-indices offer poor measures of early-career researchers' productivity and potential, Stanford University's Richard Zare argues in Angewandte Chemie this week. "Just as the IQ number does not capture the creativity and originality of a person's work, the h-index is not a full measure," Zare says. "Some rough correlations do exist, but in judging researchers early in their career, the h-index seems to be a poor measure.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.